Revenue by quarter

DKKm

Q2
2008

Q2
2007

 

Europe

 

 

 

Cipralex®

857

706

     

Ebixa®

387

334

 

Azilect®

58

37

 

Serdolect®

9

4

 

Other pharmaceuticals

264

281

 

Total revenue, Europe

1,574

1,364

 

 

US**

 

Income from Lexapro®

692

641

 

Other pharmaceuticals

-

-

 

Total revenue, US

692

641

 

 

International Markets***

 

Cipralex®

377

321

 

Ebixa®

81

74

 

Azilect®

5

3

 

Serdolect®

5

2

 

Other pharmaceuticals

152

150

 

Total revenue, International Markets

621

550

 

Other revenue

51

57

 

Total group revenue

2,938

2,612